CR
Caribou Biosciences, Inc.
CRBU · NASDAQ
$1.30 -0.76% (-$0.01)
1M -20.73%
Market Cap $128.9M
P/E Ratio -
Div. Yield -
ROE 89.11%
Bulios Fair Price
$1.28
1.5% downside
Trenutna cena
$1.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica CRBU trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/B 1.31x
P/S 12.85x
PEG N/A
Growth
0 /100
Declining Book val. growth 25.95%
Rev. growth 6.95%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 954.18%
Op. margin 1,090.90%
Gross margin 129.70%
Quality
1 /100
Poor Asset turnover 0.07x
ROA 72.42%
ROIC 86.30%
Debt
100 /100
Low Current ratio 6.49x
Debt/Equity 0.27x
Net debt/EBITDA N/A
Stability
29 /100
Unstable Profitable years 0
EPS volatility 17.99%
Beta 2.28x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRBU
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rachel E. Haurwitz
Employees
97
Headquarters
Berkeley
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report